Frost & Sullivan commends Merck Serono for its excellence in product differentiation
“Merck Serono is lauded for its cutting-edge drug delivery devices - easypod® and cool.click®2 – that facilitate the simple and effective administration of Saizen®, the recombinant HGH used for the treatment of endogenous growth hormone deficiency in children and adults,” noted Frost & Sullivan Healthcare Senior Research Analyst Aiswariya Chidambaram. “These devices successfully address long standing challenges related to poor patient compliance and low adherence to HGH therapy.”
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.